Cerus Corporation announced the appointment of Eric Bjerkholt to its Board of Directors. Mr. Bjerkholt currently serves as the chief financial officer of Aimmune Therapeutics. Mr. Bjerkholt began his healthcare career in investment banking at J.P. Morgan. Mr. Bjerkholt currently serves on the board and is the chair of the audit committee of Corium International Inc.